TCM

Tang Capital Management Portfolio holdings

AUM $1.98B
This Quarter Return
+47.93%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$1.08B
AUM Growth
+$1.08B
Cap. Flow
+$243M
Cap. Flow %
22.47%
Top 10 Hldgs %
41.77%
Holding
136
New
30
Increased
24
Reduced
21
Closed
13

Top Buys

1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$81M
2
LIAN
LianBio American Depositary Shares
LIAN
$33.8M
3
PTCT icon
PTC Therapeutics
PTCT
$24.8M
4
IMGN
Immunogen Inc
IMGN
$20.7M
5
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$20.4M

Top Sells

1
EQRX
EQRx, Inc. Common Stock
EQRX
$22.4M
2
THRD
Third Harmonic Bio
THRD
$11.5M
3
NVCR icon
NovoCure
NVCR
$7.95M
4
NTLA icon
Intellia Therapeutics
NTLA
$6.02M
5
BCRX icon
BioCryst Pharmaceuticals
BCRX
$5.99M

Sector Composition

1 Healthcare 95.77%
2 Financials 3.5%
3 Real Estate 0.65%
4 Technology 0.08%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NKTR icon
101
Nektar Therapeutics
NKTR
$568M
$1.33M 0.12% 2,348,109 -1,591,491 -40% -$899K
ARE icon
102
Alexandria Real Estate Equities
ARE
$14.1B
$1.27M 0.12% +10,000 New +$1.27M
DTIL icon
103
Precision BioSciences
DTIL
$57.8M
$1.24M 0.11% +3,400,000 New +$1.24M
MASS icon
104
908 Devices
MASS
$226M
$1.12M 0.1% 100,000 – –
VNDA icon
105
Vanda Pharmaceuticals
VNDA
$279M
$1.05M 0.1% +248,190 New +$1.05M
ABOS icon
106
Acumen Pharmaceuticals
ABOS
$82.4M
$948K 0.09% +246,895 New +$948K
TSP
107
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$878K 0.08% +1,000,000 New +$878K
GOSS icon
108
Gossamer Bio
GOSS
$562M
$765K 0.07% 838,600 – –
ATYR
109
aTyr Pharma
ATYR
$527M
$664K 0.06% 471,134 – –
SYRS
110
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$662K 0.06% +85,031 New +$662K
EGRX
111
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$622K 0.06% 118,857 – –
STIM icon
112
Neuronetics
STIM
$220M
$580K 0.05% 200,000 – –
STEL icon
113
Stellar Bancorp
STEL
$1.59B
$557K 0.05% 20,000 – –
NXTC icon
114
NextCure
NXTC
$13.5M
$533K 0.05% 467,922 +67,922 +17% +$77.4K
MOLN
115
Molecular Partners
MOLN
$140M
$418K 0.04% 100,000 – –
TRVI icon
116
Trevi Therapeutics
TRVI
$883M
$402K 0.04% +300,000 New +$402K
XERS icon
117
Xeris Biopharma Holdings
XERS
$1.26B
$353K 0.03% 150,000 – –
ERAS icon
118
Erasca
ERAS
$445M
$320K 0.03% +150,000 New +$320K
KZR icon
119
Kezar Life Sciences
KZR
$28.9M
$291K 0.03% +306,665 New +$291K
EQ icon
120
Equillium
EQ
$62.2M
$289K 0.03% 400,000 – –
RNAC icon
121
Cartesian Therapeutics
RNAC
$261M
$276K 0.03% 400,000 – –
WGS icon
122
GeneDx Holdings
WGS
$3.72B
$175K 0.02% 63,636 – –
TLPH icon
123
Talphera
TLPH
$11.1M
$143K 0.01% 195,000 – –
C icon
124
Citigroup
C
$178B
– – -100,000 Closed -$4.11M
CHRS icon
125
Coherus Oncology, Inc. Common Stock
CHRS
$135M
– – -400,000 Closed -$1.5M
2 3 4
5
6